GHRP-2 Treatment Changes Pituitary Cell Gene Expression for Multiple GH-Axis Components

GHRP-2 treatment in vitro modified pituitary cell expression of GH, pit-1 transcription factor, GHRH receptor, and GHS receptor — revealing how GH secretagogues reprogram pituitary cells for sustained responsiveness.

Yan, Ming et al.·European journal of endocrinology·2004·Preliminary Evidencein-vitro
RPEP-01001In VitroPreliminary Evidence2004RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

In-vitro GHRP-2 treatment altered pituitary somatotroph expression of GH, Pit-1 transcription factor, GHRH-R, and GHS-R at mRNA and protein levels, demonstrating GH secretagogue-induced pituitary cell reprogramming for enhanced GH-axis responsiveness.

Key Numbers

How They Did This

in-vitro study on ghrp, cjc-1295.

Why This Research Matters

Relevant for ghrp, cjc-1295, hormone-optimization, receptor-signaling.

The Bigger Picture

Advances peptide/biomarker research with clinical implications.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding In-vitro GHRP-2 treatment altered pituitary somatotroph expression of GH, Pit-1 transcription factor, GHRH-R, and GHS-R at mRNA and protein levels, de
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2004.
Original Title:
Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.
Published In:
European journal of endocrinology, 150(2), 235-42 (2004)
Database ID:
RPEP-01001

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

GHRP-2 Treatment Changes Pituitary Cell Gene Expression for Multiple GH-Axis Components

What was found?

GHRP-2 treatment in vitro modified pituitary cell expression of GH, pit-1 transcription factor, GHRH receptor, and GHS receptor — revealing how GH secretagogues reprogram pituitary cells for sustained responsiveness.

Read More on RethinkPeptides

Cite This Study

RPEP-01001·https://rethinkpeptides.com/research/RPEP-01001

APA

Yan, Ming; Hernandez, Maria; Xu, Ruwei; Chen, Chen. (2004). Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.. European journal of endocrinology, 150(2), 235-42.

MLA

Yan, Ming, et al. "Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.." European journal of endocrinology, 2004.

RethinkPeptides

RethinkPeptides Research Database. "Effect of GHRH and GHRP-2 treatment in vitro on GH secretion..." RPEP-01001. Retrieved from https://rethinkpeptides.com/research/yan-2004-effect-of-ghrh-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.